StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Sanofi
Paris Stock Exchange:SAN.PA
Sector
Location
Market Cap
USD 118.11 B
Share Price
USD 97.05
Avg Daily Volume
2,240,720
Change (1 day)
-1.44%
Change (1 year)
-4.81%
Change (YTD)
-0.02%
Sanofi Operating Cash Flow for the year ending December 31, 2024: USD 9.40 B
Sanofi Operating Cash Flow is USD 9.40 B for the year ending December 31, 2024, a -16.95% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Sanofi Operating Cash Flow for the year ending December 31, 2023 was USD 11.32 B, a 0.53% change year over year.
-
Sanofi Operating Cash Flow for the year ending December 31, 2022 was USD 11.26 B, a -5.97% change year over year.
-
Sanofi Operating Cash Flow for the year ending December 31, 2021 was USD 11.98 B, a 31.63% change year over year.
-
Sanofi Operating Cash Flow for the year ending December 31, 2020 was USD 9.10 B, a 4.71% change year over year.
Competitors
Swedish Orphan Biovitrum AB (publ)
USD 29.78
SOBI.ST
-0.91
-2.98%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.30
603392.SS
-0.05
-0.62%
Ionis Pharmaceuticals, Inc.
USD 41.73
IONS
-0.65
-1.53%
Rhythm Pharmaceuticals, Inc.
USD 86.70
RYTM
-2.34
-2.63%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.97
1877.HK
-0.03
-1.06%
Hualan Biological Engineering Inc.
USD 2.22
002007.SZ
+0.01
0.65%
NewAmsterdam Pharma Company N.V.
USD 21.54
NAMS
-0.48
-2.18%
Ligand Pharmaceuticals Incorporated
USD 121.70
LGND
-3.28
-2.62%
Apellis Pharmaceuticals, Inc.
USD 19.44
APLS
-0.09
-0.46%
Apogee Therapeutics, Inc.
USD 38.14
APGE
-0.43
-1.11%
Adaptive Biotechnologies Corporation
USD 11.82
ADPT
-0.26
-2.15%
ARS Pharmaceuticals, Inc.
USD 17.69
SPRY
-0.29
-1.61%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Swedish Orphan Biovitrum AB (publ)
USD 29.78
SOBI.ST
-0.91
-2.98%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.30
603392.SS
-0.05
-0.62%
Ionis Pharmaceuticals, Inc.
USD 41.73
IONS
-0.65
-1.53%
Rhythm Pharmaceuticals, Inc.
USD 86.70
RYTM
-2.34
-2.63%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.97
1877.HK
-0.03
-1.06%
Hualan Biological Engineering Inc.
USD 2.22
002007.SZ
+0.01
0.65%
NewAmsterdam Pharma Company N.V.
USD 21.54
NAMS
-0.48
-2.18%
Ligand Pharmaceuticals Incorporated
USD 121.70
LGND
-3.28
-2.62%
Apellis Pharmaceuticals, Inc.
USD 19.44
APLS
-0.09
-0.46%
Apogee Therapeutics, Inc.
USD 38.14
APGE
-0.43
-1.11%
Adaptive Biotechnologies Corporation
USD 11.82
ADPT
-0.26
-2.15%
ARS Pharmaceuticals, Inc.
USD 17.69
SPRY
-0.29
-1.61%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%